Game-Changing Solution for Heart Inflammation? | David Elsley – Cardiol Therapeutics
In this interview with David Elsley, President and CEO of Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL), we explore the company’s innovative approach to treating inflammatory heart conditions.
Read more